Comparative analysis of type 2 diabetes-associated gut microbiota between Han and Mongolian people
Tóm tắt
Due to the different rates of diabetes in different ethnic groups and the structural differences in intestinal microbiota, this study evaluated the changes in diabetes-related intestinal microbiota in two ethnic groups. Fifty-six stool samples were collected from subjects from the Han and Mongolian ethnic groups in China, including participants without diabetes (non-diabetic, ND) and with type 2 diabetes (T2D). The 16S rDNA gene V3 + V4 area was extracted from microbiota, amplified by PCR, and used to perform high-throughput sequencing and screen differential microbiota associated with ethnicity. The results showed that there were 44 T2D-related bacterial markers in the Han subjects, of which Flavonifractor, Alistipes, Prevotella, Oscillibacter, Clostridium XlVa, and Lachnospiracea_incertae_sedis were most closely related to diabetes. There were 20 T2D-related bacterial markers in the Mongolian subjects, of which Fastidiosipila and Barnesiella were most closely related to diabetes. The common markers of T2D bacteria in the two ethnic groups were Papillibacter and Bifidobacterium. There were 17 metabolic pathways with significant differences between the ND and T2D groups in the Han group, and 29 metabolic pathways in the Mongolian group. The glutamatergic metabolic pathway was the only common metabolic pathway in two ethnic groups. The composition and function of diabetes-related bacteria were significantly different among the different ethnic groups, which suggested that the influence of ethnic differences should be fully considered when studying the association between diabetes and bacteria. In addition, the common bacterial markers found in diabetic patients of different ethnic groups in this study can be used as potential targets to study the pathogenesis and treatment of diabetes.
Tài liệu tham khảo
Ahmad, A., Yang, W., Chen, G., Shafiq, M., Javed, S., Ali Zaidi, S.S., Shahid, R., Liu, C., and Bokhari, H. 2019. Analysis of gut micro-biota of obese individuals with type 2 diabetes and healthy individuals. PLoS ONE 14, e0226372.
American Diabetes Association. 2020. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 43, S14–S31.
Beal, M.J., Falciani, F., Ghahramani, Z., Rangel, C., and Wild, D.L. 2005. A Bayesian approach to reconstructing genetic regulatory networks with hidden factors. Bioinformatics 21, 349–356.
Brooks, A.W., Priya, S., Blekhman, R., and Bordenstein, S.R. 2018. Gut microbiota diversity across ethnicities in the United States. PLoS Biol. 16, e2006842.
Brunkwall, L. and Orho-Melander, M. 2017. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia 60, 943–951.
Chen, M., Hui, S., Lang, H., Zhou, M., Zhang, Y., Kang, C., Zeng, X., Zhang, Q., Yi, L., and Mi, M. 2019. SIRT3 deficiency promotes high-fat diet-induced nonalcoholic fatty liver disease in correlation with impaired intestinal permeability through gut microbial dysbiosis. Mol. Nutr. Food Res. 63, e1800612.
Fassatoui, M., Lopez-Siles, M., Díaz-Rizzolo, D.A., Jmel, H., Naouali, C., Abdessalem, G., Chikhaoui, A., Nadal, B., Jamoussi, H., Abid, A., et al. 2019. Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus. Biosci. Rep. 39, BS20182348.
Harbison, J.E., Roth-Schulze, A.J., Giles, L.C., Tran, C.D., Ngui, K.M., Penno, M.A., Thomson, R.L., Wentworth, J.M., Colman, P.G., Craig, M.E., et al. 2019. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. Pediatr. Diabetes 20, 574–583.
Hernández, M.A.G., Canfora, E.E., Jocken, J.W.E., and Blaak, E.E. 2019. The short-chain fatty acid acetate in body weight control and insulin sensitivity. Nutrients 11, 1943.
Huang, P. and Liu, Y. 2019. A reasonable diet promotes balance of intestinal microbiota: prevention of precolorectal cancer. Biomed Res. Int. 2019, 3405278.
Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., Tkach, S., et al. 2017. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 17, 120.
Leiva-Gea, I., Sánchez-Alcoholado, L., Martín-Tejedor, B., Castellano-Castillo, D., Moreno-Indias, I., Urda-Cardona, A., Tinahones, F.J., Fernández-García, J.C., and Queipo-Ortuño, M.I. 2018. Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study. Diabetes Care 41, 2385–2395.
Li, N.N., Bai, C.M., Zhao, L., and Ge, Y.P. 2019. Gut microbiome differences between gastrointestinal cancer patients and healthy people. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 41, 636–645.
Lin, H. 2017. M.S. thesis. Minzu University of China, Beijing, China.
Liu, Y., Cao, P., Ma, H., and Liu, X. 2019. Gut bacterial community diversity in healthy Tibetan and Han college students. Acta Microbiol. Sin. 59, 1674–1684.
Lopez-Siles, M., Enrich-Capó, N., Aldeguer, X., Sabat-Mir, M., Duncan, S.H., Garcia-Gil, L.J., and Martinez-Medina, M. 2018. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front. Cell. Infect. Microbiol. 8, 281.
Ma, Z.Z., Cheng, Y.Y., Wang, S.Q., Ge, J.Z., Shi, H.P., and Kou, J.C. 2020. Positive effects of dietary supplementation of three probiotics on milk yield, milk composition and intestinal flora in Sannan dairy goats varied in kind of probiotics. J. Anim. Physiol. Anim. Nutr. 104, 44–55.
Ma, Q., Li, Y., Li, P., Wang, M., Wang, J., Tang, Z., Wang, T., Luo, L., Wang, C., Wang, T., et al. 2019. Research progress in the relationship between type 2 diabetes mellitus and intestinal flora. Biomed. Pharmacother. 117, 109138.
Parker, B.J., Wearsch, P.A., Veloo, A.C.M., and Rodriguez-Palacios, A. 2020. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front. Immunol. 11, 906.
Petrov, V.A., Saltykova, I.V., Zhukova, I.A., Alifirova, V.M., Zhukova, N.G., Dorofeeva, Y.B., Tyakht, A.V., Kovarsky, B.A., Alekseev, D.G., Kostryukova, E.S., et al. 2017. Analysis of gut microbiota in patients with parkinson’s disease. Bull. Exp. Biol. Med. 162, 734–737.
Rau, M., Rehman, A., Dittrich, M., Groen, A.K., Hermanns, H.M., Seyfried, F., Beyersdorf, N., Dandekar, T., Rosenstiel, P., and Geier, A. 2018. Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United European Gastroenterol. J. 6, 1496–1507.
Robinson, M.D., McCarthy, D.J., and Smyth, G.K. 2010. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140.
Rodriguez, J., Hiel, S., Neyrinck, A.M., Le Roy, T., Pötgens, S.A., Leyrolle, Q., Pachikian, B.D., Gianfrancesco, M.A., Cani, P.D., Paquot, N., et al. 2020. Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut 69, 1975–1987.
Salah, M., Azab, M., Ramadan, A., and Hanora, A. 2019. New insights on obesity and diabetes from gut microbiome alterations in Egyptian adults. OMICS 23, 477–485.
Sebastián Domingo, J.J. and Sánchez Sánchez, C. 2018. From the intestinal flora to the microbiome. Rev. Esp. Enferm. Dig. 110, 51–56.
Tan, H., Zhai, Q., and Chen, W. 2019. Investigations of Bacteroides spp. towards next-generation probiotics. Food Res. Int. 116, 637–644.
Upadhyaya, S. and Banerjee, G. 2015. Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes 6, 85–92.
Wei, X., Tao, J., Xiao, S., Jiang, S., Shang, E., Zhu, Z., Qian, D., and Duan, J. 2018. Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota. Sci. Rep. 8, 3685.
Wei, L., Wu, Q., Zhang, J., Guo, W., Gu, Q., Wu, H., Wang, J., Lei, T., Chen, M., Wu, M., et al. 2019. Composition and dynamics of bacterial communities in a full-scale mineral water treatment plant. Front. Microbiol. 10, 1542.
Yan, S. and Li, H. 2017. Review of diabetes mellitus prevalence in China. J. Kunming Medical University 38, 1–5.
Zeng, H., Umar, S., Rust, B., Lazarova, D., and Bordonaro, M. 2019. Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int. J. Mol. Sci. 20, 1214.
Zhou, W., Yan, Y., Mi, J., Zhang, H., Lu, L., Luo, Q., Li, X., Zeng, X., and Cao, Y. 2018. Simulated digestion and fermentation in vitro by human gut microbiota of polysaccharides from bee collected pollen of chinese wolfberry. J. Agric. Food Chem. 66, 898–907.
Zibaidan, A. 2017. M.S. thesis. Xinjiang Medical University, Beijing, China.
Zuo, K., Li, J., Li, K., Hu, C., Gao, Y., Chen, M., Hu, R., Liu, Y., Chi, H., Wang, H., et al. 2019. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience 8, giz058.